Product Information
TUSSIN DM 20-200 MG/10 ML LIQ is a generic product labeled by Aarna USA Inc., priced at $0.0111 per ML under NDC 82568001504. Its NADAC has been published 42 times since Dec 17, 2025.
Strength
20; 200 mg/10mL; mg/10mL
Manufacturer
Aarna USA Inc.NDC
82568001504
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
2/18/2025
Pharmacological Classes
Price Statistics
The NADAC for TUSSIN DM 20-200 MG/10 ML LIQ has been published 42 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0111 per ML |
|---|---|
| All-time high | $0.0111 (Apr 15, 2026) |
| All-time low | $0.0110 (Jun 17, 2026) |
| 52-week high | $0.0111 |
| 52-week low | $0.0110 |
| Median price | $0.0111 |
| Average price | $0.0111 |
| Largest weekly change | -0.3% (May 20, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr and Guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aarna USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr and Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TUSSIN DM 20-200 MG/10 ML LIQ?
The current National Average Drug Acquisition Cost (NADAC) for TUSSIN DM 20-200 MG/10 ML LIQ, manufactured by Aarna USA Inc., is $0.0111 per ML (NDC 82568001504), effective Sep 30, 2026.
How has the price of TUSSIN DM 20-200 MG/10 ML LIQ changed over time?
Over the history we have for it, the NADAC for TUSSIN DM 20-200 MG/10 ML LIQ has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for TUSSIN DM 20-200 MG/10 ML LIQ?
Since Dec 17, 2025, the NADAC for TUSSIN DM 20-200 MG/10 ML LIQ has ranged from a low of $0.0110 (Jun 17, 2026) to a high of $0.0111 (Apr 15, 2026), with a median of $0.0111 per ML.
Are there cheaper alternatives to TUSSIN DM 20-200 MG/10 ML LIQ?
No other NADAC-published product currently shares the active ingredient and strength of TUSSIN DM 20-200 MG/10 ML LIQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TUSSIN DM 20-200 MG/10 ML LIQ?
TUSSIN DM 20-200 MG/10 ML LIQ (NDC 82568001504) is labeled by Aarna USA Inc., and CMS classifies it as a generic product.